Brandywine Oak Private Wealth LLC Eli Lilly & CO Put Options Transaction History

Brandywine Oak Private Wealth LLC

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 07, 2024	SELL	$772.14 - $960.02 $617,712 - $768,016	-800 Reduced 42.11%	1,100 $974,000
Q2 2024 Jul 30, 2024	SELL	$724.87 - $909.04 $869,844 - $1.09 Million	-1,200 Reduced 38.71%	1,900 $1.72 Million
Q1 2024 May 07, 2024	SELL	$592.2 - $792.28 $236,880 - $316,912	-400 Reduced 11.43%	3,100 $2.41 Million
Q4 2023 Feb 05, 2024	SELL	$525.19 - $619.13 $9.45 Million - $11.1 Million	-18,000 Reduced 83.72%	3,500 $2.04 Million
Q3 2023 Nov 14, 2023	BUY	$434.7 - $599.3 $7.82 Million - $10.8 Million	18,000 Added 514.29%	21,500 $11.5 Million
Q4 2022 Feb 06, 2023	BUY	$321.55 - $374.67 $1.13 Million - $1.31 Million	3,500 New	3,500 $1.28 Million

4,011

751M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $744B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Brandywine Oak Private Wealth LLC, based on Form 13F filings with the SEC.

Stay updated on Brandywine Oak Private Wealth LLC with notifications on news.